NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

Rhea-AI Summary

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC), a medical technology company specializing in neurological disorder surgical care solutions, has announced its participation in the upcoming MedInvest MedTech, AI and Digital Health Conference. The event will take place on June 3-4, 2025, at the O'Melveny Conference Center in San Francisco, CA.

Dave Rosa, President and CEO of NeuroOne, will be conducting investor meetings during this two-day conference, which will feature panel discussions, keynote talks, and corporate presentations focusing on medical devices, imaging technologies, diagnostics, AI/data analytics, and digital health. The MedInvest Conference is recognized as a leading conference series in Healthcare and Life Sciences, hosting semiannual events in Biotech, Pharma, MedTech, AI, and Digital Health sectors.

News Market Reaction – NMTC

+0.57%

1 alert

+0.57% News Effect

On the day this news was published, NMTC gained 0.57%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the MedInvest MedTech, AI and Digital Health Conference taking place in San Francisco, CA on June 3-4, 2025.

Dave Rosa, President and CEO of NeuroOne will be meeting with investors during the two-day event that will feature informative panel discussions, keynote talks and corporate presentations on medical devices, imaging technologies, diagnostics, AI/data analytics and digital health.

MedTech, AI & Digital Health Conference
Dates: June 3-4, 2025
Location: O’Melveny Conference Center, San Francisco, CA
Conference registration: https://www.medinvestconferences.com/register

The MedInvest Conference is a leading conference series in Healthcare and Life Sciences. MedInvest hosts semiannual conferences in Biotech and Pharma and in MedTech, AI, and Digital Health. To learn more or to register, please visit their website: https://www.medinvestconferences.com/

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.

IR Contact
MZ Group – MZ North America
NMTC@mzgroup.us

FAQ

When and where is NeuroOne (NMTC) presenting at the MedInvest Conference 2025?

NeuroOne will participate in the MedInvest Conference on June 3-4, 2025, at the O'Melveny Conference Center in San Francisco, CA.

Who will represent NeuroOne (NMTC) at the MedInvest Conference 2025?

Dave Rosa, President and CEO of NeuroOne, will represent the company and meet with investors during the conference.

What is the focus of NeuroOne Medical Technologies (NMTC)?

NeuroOne is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders.

What topics will be covered at the 2025 MedInvest Conference?

The conference will cover medical devices, imaging technologies, diagnostics, AI/data analytics, and digital health through panel discussions, keynote talks, and corporate presentations.